Darbepoetin Alfa
A hyperglycosylated engineered form of erythropoietin with a longer half-life than epoetin alfa, used to stimulate red blood cell production in patients with anemia from chronic kidney disease or chemotherapy. Its modified carbohydrate structure allows less frequent dosing.
治療領域
作用機序
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
よくある質問
A hyperglycosylated engineered form of erythropoietin with a longer half-life than epoetin alfa, used to stimulate red blood cell production in patients with anemia from chronic kidney disease or chemotherapy. Its modified carbohydrate structure allows less frequent dosing.
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Yes, Darbepoetin Alfa is an approved drug. It has reached clinical phase 4. It is classified as a Protein.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201566. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="darbepoetin-alfa"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/darbepoetin-alfa/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/darbepoetin-alfa/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/darbepoetin-alfa/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="darbepoetin-alfa"></drugfyi-drug>